Acute cardiac care & resuscitation

Intraosseous vs. intravenous access during out-of-hospital cardiac arrest: a Bayesian secondary analysis of a randomised clinical trial

ResuscitationPublished Bayesian secondary analysis of a randomised clinical trial

Authors' conclusion

The probability of a clinically meaningful difference in return of spontaneous circulation between intraosseous and intravenous access for out-of-hospital cardiac arrest was very low, while results for 30-day outcomes were uncertain, with no strong evidence favouring either method.

Study context

Population
Adults with non-traumatic out-of-hospital cardiac arrestadults in the IVIO trial
Participants
1,479 adults
Comparison
Intraosseous to intravenous access
Methodological detailspre-planned in the protocol, non-informative and informative priors
  • Pre-planned in the protocol
  • Non-informative and informative priors

Primary result

As reported in the abstract

Sustained return of spontaneous circulation (non-informative priors)

Posterior probability risk ratio > 1.27, favouring intraosseous access

1.2%

Posterior probability risk ratio < 0.79 [1/1.27], favouring intravenous access

< 0.1%

Further findings

30-day survival and survival with a favourable neurologic outcome

Posterior probability risk ratio intraosseous vs intravenous between 0.83 (1/1.2) and 1.2, 30-day survival
58%
Posterior probability risk ratio intraosseous vs intravenous between 0.83 (1/1.2) and 1.2, survival with favourable neurologic outcome
55%

All outcomes, informative priors

Results did not provide probabilities strongly favouring either intraosseous or intravenous access
  • Informative priors

Original publication

Intraosseous vs. intravenous access during out-of-hospital cardiac arrest: a Bayesian secondary analysis of a randomised clinical trial. Resuscitation. Published 17 May 2025. doi:10.1016/j.resuscitation.2025.110634

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.